DocDollars

Omeros Corporation

WA · United States · Reporting entity ID 100000136485

Total reported 2019–2025
$4.26M
#761 of 2,960 reporting companies — 0% of all reported industry payments
$1.51M in general payments across 5,523 records, plus $1.77M in research funding across 114 records.

How it breaks down

General payments $1,509,654
Research funding $1,771,611
Ownership & investment $980,260

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Omeros Corporation reported $4.26M to US doctors and teaching hospitals from 2019 to 2025, ranking #761 of 2,960 reporting companies. 42% of that was research funding and 58% general payments such as consulting, speaking, food and travel. 5,523 general payment records and 114 research records were filed.

Common questions about Omeros Corporation

How much has Omeros Corporation paid US doctors?

Omeros Corporation reported $4,261,525 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,509,654 in general payments, $1,771,611 in research funding and $980,260 in ownership and investment interests.

How does Omeros Corporation rank among drug and device companies?

It ranks #761 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Omeros Corporation mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.